Donor Blood Components Market Size and Growth 2031

Q: Which region dominated the donor blood components market in 2024?

North America dominated the market in 2024... Read more

Donor Blood Components Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography

Report Code : TIPRE00040976
Category : Life Sciences

No. of Pages : 342

Buy Now

The donor blood components market size is projected to reach US$ 14.64 billion by 2031 from US$ 10.08 billion in 2024. The market is expected to register a CAGR of 5.7% during 2025–2031. The rising demand for plasma-derived therapies is likely to bring in new market trends during the forecast period.

Donor Blood Components Market Analysis

The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.

Donor Blood Components Market Overview

The donor blood components market is rapidly expanding due to the rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness. Prominent players operating in the market are focusing on innovations and collaborative efforts for enhanced product availability and reach. However, the inconsistent voluntary donations hinder market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Donor Blood Components Market: Strategic Insights

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst

Donor Blood Components Market Drivers and Opportunities

Rising Prevalence of Cancer and Immunosuppressive Diseases Fuel Market Growth

The incidence of cancer and immunosuppressive disorders is increasing across the globe. Cancer patients frequently demand RBCs and platelet transfusions due to the adverse effects of chemotherapy, radiation, and bone marrow transplantation, which lead to anaemia and thrombocytopenia. As per the American Cancer Society, in the US, ~2 million new cancer cases were diagnoses in 2024, where estimated numbers of lymphoma were 89,190, Myeloma were 35,780, and Leukemia were 62,770. Most patients rely significantly on transfusions of blood components to cope with side effects and enhance quality of life.

Patients with immunosuppressed diseases such as HIV/AIDS, autoimmune diseases, and those on immunosuppressive therapy following organ transplantation need plasma-derived products such as immunoglobulins and clotting factors in order to enhance immune function and avert infections. In 2023, the Joint United Nations Programme on HIV/AIDS (UNAIDS) reported that more than 39.9 million individuals were living with HIV worldwide, with many relying on blood components for survival.

According to GLOBOCAN estimates, the worldwide cancer prevalence is estimated to account for more than 28.4 million new cases per year by 2040, which will significantly boost demand for blood components in oncology treatment centers and hospitals. Furthermore, the rising population of older persons, who are more prone to cancer and immunosuppressive illnesses, drives demand for a secure and trustworthy blood supply.

These increasing health conditions highlight the paramount need for the constant provision of blood donation and high-tech blood component processing technologies. Healthcare institutions and blood banks are expanding their capability to keep up with this demand. Therefore, the increasing prevalence of cancer and immunosuppressive disorders boosts the donor blood component market growth.

Emerging Market Demand to Create Lucrative Opportunities in the Market

Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public–private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.

According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.

The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.

Donor Blood Components Market Report Segmentation Analysis

Key segments that contributed to the derivation of the donor blood components market analysis are blood component, indication, application, age group, and end user.

Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.
By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.
In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.
By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.
As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.

Donor Blood Components Market Share Analysis by Geography

The geographic scope of the donor blood components market report mainly focuses on five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2024. It is expected to continue its dominance in the global market during the forecast period. The US is the largest market for donor blood components in the world. According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. Cancer patients require regular blood transfusions during chemotherapy treatment. Chemotherapy and radiation therapies often lead to severe thrombocytopenia and neutropenia, necessitating platelet and plasma transfusions to prevent life-threatening bleeding and infections. According to The Leukemia & Lymphoma Society Facts and Statistics Overview, one person in the US is diagnosed with leukemia, lymphoma, or myeloma every 3 minutes. Also, ~456,481 people are living with leukemia. Leukemia affects bone marrow, reducing healthy blood cell production and causing anemia, which makes frequent transfusions of red cells, platelets, and plasma essential.

To meet the growing demand for blood components, blood banks and organizations, such as the American National Red Cross and the Association for the Advancement of Blood & Biotherapies, have intensified donor recruitment and blood collection efforts. As per the American National Red Cross, every two seconds, someone in the country needs blood or platelets for surgeries, cancer treatment, chronic illnesses, and traumatic injuries. ~29,000 units of RBCs, 5,000 units of platelets, and 6.500 units of plasma are needed every day in the nation. Per the same source, an estimated 6.8 million people donate blood each year in the US. This donation adds up to ~13.6 million units of whole blood and RBCs collected annually in the country. The American National Red Cross provides ~40% of the nation’s blood and blood cell components to donors, and ~16 million blood components are transfused annually in the US.

Furthermore, increasing demand for organ transplantation is likely to propel the demand for blood components. As per the data from the Organ Procurement and Transplantation Network (OPTN), the number of transplants performed in the country increased from 41,000 in 2021 to 48,149 in 2024. On average, the nation performed 132 transplants a day in 2024. During transplant surgeries, patients often experience substantial blood loss, requiring large quantities of blood to maintain stable circulation and support organ function. Recipients may need blood transfusions before and after surgery to manage anemia, boost recovery, and counter immune suppression therapies that can affect blood cell production.

Donor Blood Components Market Report Scope

Donor Blood Components Market News and Recent Developments

The donor blood components market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Key developments witnessed in the donor blood components market are as follows:

Red Cross and Armed Services Blood Program launch partnership to strengthen military and civilian blood supply. (Source: The American National Red Cross, Company News, July 2025)
NHS calls for 200,000 new blood donors as supplies run low. (Source: NHS Blood and Transplant (NHSBT), Press Release, XX 2024)

Donor Blood Components Market Report Coverage and Deliverables

The "Donor Blood Components Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Donor blood components market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Donor blood components market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Donor blood components market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the donor blood components market
Detailed company profiles

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

What are the factors driving the donor blood components market growth?

The rising prevalence of cancer and immunosuppressive diseases and increasing donor awareness are among the significant factors fueling the market growth.

Which region dominated the donor blood components market in 2024?

North America dominated the market in 2024.

What are the future trends in the donor blood components market?

The rising demand for plasma-derived therapies is likely to emerge as a new growth trend in the market in the coming years.

Which are the leading players operating in the donor blood components market?

Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key players operating in the market.

What is the expected CAGR of the donor blood components market?

The market is expected to register a CAGR of 5.7% during 2025–2031.

What would be the estimated value of the donor blood components market by 2031?

The market value is expected to reach US$ 14.64 billion by 2031.

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

3.3 Assumptions and Limitations

4. Donor Blood Component Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024

4.4 Global Disease Prevalence of 5 Key Diseases, 2024

5. Donor Blood Component Market – Key Market Dynamics

5.1 Donor Blood Component Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases

5.2.2 Increasing Donor Awareness

5.3 Market Restraints

5.3.1 Inconsistent Voluntary Donations

5.4 Market Opportunities

5.4.1 Emerging Market Demand

5.5 Future Trends

5.5.1 Rising Demand for Plasma-Derived Therapies

5.6 Impact of Drivers and Restraints:

6. Donor Blood Component Market – Global Market Analysis

6.1 Donor Blood Component Market Revenue (US$ Million), 2021–2031

6.2 Donor Blood Component Market Forecast Analysis

7. Donor Blood Component Market Analysis – by Blood Component

7.1 Red Blood Cells

7.1.1 Overview

7.1.2 Red Blood Cells: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

7.2 White blood cells

7.2.1 Overview

7.2.2 White blood cells: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Platelets

7.3.1 Overview

7.3.2 Platelets: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Plasma

7.4.1 Overview

7.4.2 Plasma: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

8. Donor Blood Component Market Analysis – by Indication

8.1 Immunosuppression

8.1.1 Overview

8.1.2 Immunosuppression: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Oncology

8.2.1 Overview

8.2.2 Oncology: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9. Donor Blood Component Market Analysis – by Application

9.1 Anemia management

9.1.1 Overview

9.1.2 Anemia management: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Thrombocytopenia treatment

9.2.1 Overview

9.2.2 Thrombocytopenia treatment: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Coagulopathy Correction

9.3.1 Overview

9.3.2 Coagulopathy Correction: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9.4 Supportive care during chemotherapy

9.4.1 Overview

9.4.2 Supportive care during chemotherapy: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9.5 Surgery

9.5.1 Overview

9.5.2 Surgery: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

10. Donor Blood Component Market Analysis – by Age Group

10.1 Adult

10.1.1 Overview

10.1.2 Adult: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

10.2 Child

10.2.1 Overview

10.2.2 Child: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

11. Donor Blood Component Market Analysis – by End User

11.1 Hospitals

11.1.1 Overview

11.1.2 Hospitals: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

11.2 Oncology centers

11.2.1 Overview

11.2.2 Oncology centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

11.3 Transplant centers

11.3.1 Overview

11.3.2 Transplant centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

11.4 Ambulatory surgical centers

11.4.1 Overview

11.4.2 Ambulatory surgical centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

12. Donor Blood Component Market – Geographical Analysis

12.1 North America

12.1.1 North America Donor Blood Component Market Overview

12.1.2 North America: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

12.1.2.1 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Blood Component

12.1.2.2 North America: Donor Blood Component Market – Volume and Forecast Analysis – by Blood Component

12.1.2.3 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Indication

12.1.2.3.1 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Immunosuppression

12.1.2.3.2 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Oncology

12.1.2.4 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Application

12.1.2.5 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Age Group

12.1.2.6 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by End User

12.1.3 North America: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.1.3.1 United States: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication

12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression

12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology

12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application

12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group

12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User

12.1.3.2 Canada: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication

12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,

12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology

12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application

12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group

12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User

12.1.3.3 Mexico: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component

12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication

12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression

12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology

12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application

12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group

12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User

12.2 Europe

12.2.1 Europe Donor Blood Component Market Overview

12.2.2 Europe: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

12.2.2.1 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Blood Component

12.2.2.2 Europe: Donor Blood Component Market – Volume and Forecast Analysis – by Blood Component

12.2.2.3 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Indication

12.2.2.3.1 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Immunosuppression

12.2.2.3.2 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Oncology

12.2.2.4 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Application

12.2.2.5 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Age Group

12.2.2.6 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by End User

12.2.3 Europe: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.2.3.1 Germany: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication

12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology

12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application

12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group

12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User

12.2.3.2 United Kingdom: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication

12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology

12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application

12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group

12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User

12.2.3.3 France: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication

12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology

12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application

12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group

12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User

12.2.3.4 Spain: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication

12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology

12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application

12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group

12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User

12.2.3.5 Italy: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication

12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology

12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application

12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group

12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User

12.2.3.6 Rest of Europe: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component

12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication

12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression

12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology

12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application

12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group

12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User

12.3 Asia Pacific

12.3.1 Asia Pacific Donor Blood Component Market Overview

12.3.2 Asia Pacific: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

12.3.2.1 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Blood Component

12.3.2.2 Asia Pacific: Donor Blood Component Market – Volume and Forecast Analysis – by Blood Component

12.3.2.3 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Indication

12.3.2.3.1 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Immunosuppression

12.3.2.3.2 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Oncology

12.3.2.4 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Application

12.3.2.5 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Age Group

12.3.2.6 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by End User

12.3.3 Asia Pacific: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.3.3.1 China: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication

12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology

12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application

12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group

12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User

12.3.3.2 Japan: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication

12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology

12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application

12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group

12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User

12.3.3.3 India: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication

12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology

12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application

12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group

12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User

12.3.3.4 Australia: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication

12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology

12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application

12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group

12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User

12.3.3.5 South Korea: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication

12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology

12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application

12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group

12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User

12.3.3.6 Rest of APAC: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component

12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication

12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression

12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology

12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application

12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group

12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User

12.4 Middle East and Africa

12.4.1 Middle East and Africa Donor Blood Component Market Overview

12.4.2 Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

12.4.2.1 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Blood Component

12.4.2.2 Middle East and Africa: Donor Blood Component Market – Volume and Forecast Analysis – by Blood Component

12.4.2.3 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Indication

12.4.2.3.1 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Immunosuppression

12.4.2.3.2 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Oncology

12.4.2.4 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Application

12.4.2.5 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Age Group

12.4.2.6 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by End User

12.4.3 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.4.3.1 Middle East and Africa: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.4.3.2 Saudi Arabia: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication

12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression

12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology

12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application

12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group

12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User

12.4.3.3 South Africa: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication

12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression

12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology

12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application

12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group

12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User

12.4.3.4 United Arab Emirates: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication

12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression

12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology

12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application

12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group

12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User

12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component

12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication

12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression

12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology

12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application

12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group

12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User

12.5 South and Central America

12.5.1 South and Central America Donor Blood Component Market Overview

12.5.2 South and Central America: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

12.5.2.1 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Blood Component

12.5.2.2 South and Central America: Donor Blood Component Market – Volume and Forecast Analysis – by Blood Component

12.5.2.3 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Indication

12.5.2.3.1 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Immunosuppression

12.5.2.3.2 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Oncology

12.5.2.4 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Application

12.5.2.5 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Age Group

12.5.2.6 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by End User

12.5.3 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.5.3.1 South and Central America: Donor Blood Component Market – Revenue and Forecast Analysis – by Country

12.5.3.2 Brazil: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication

12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression

12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology

12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application

12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group

12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User

12.5.3.3 Argentina: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication

12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression

12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology

12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application

12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group

12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User

12.5.3.4 Rest of South and Central America: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component

12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication

12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression

12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology

12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application

12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group

12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Donor Blood Component Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. COMPANY PROFILES

14.1 Roswell Park Comprehensive Cancer Center

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Policlinico of Milan

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.3 Vitalant

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MD Anderson Cancer Center.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.5 The Johns Hopkins Hospital

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.6 The Royal Marsden

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.7 Gustave Roussy

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.8 Peter MacCallum Cancer Centre

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.9 Tata Memorial Hospital

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Memorial Sloan Kettering Cancer Center

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

List of Tables

Table 1. Donor Blood Component Market Segmentation

Table 2. Average Selling Price Per Unit (US$) of Blood Components, 2024

Table 3. Global Disease Prevalence of 5 Key Diseases, 2024

Table 4. Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 5. Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 6. Donor Blood Component Market – Volume, 2021–2024 (Units Million) – by Blood Component

Table 7. Donor Blood Component Market – Volume, 2021–2024 (Units Million) – by Blood Component

Table 8. Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 9. Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 10. Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 11. Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 12. Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 13. Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 14. Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 15. Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 16. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 17. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 18. North America: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 19. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 20. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 21. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 22. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 23. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 24. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 25. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 26. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 27. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 28. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 29. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 30. North America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 31. North America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 32. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 33. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 34. United States: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 35. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 36. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 37. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 38. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 39. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 40. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 41. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 42. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 43. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 44. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 45. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 46. United States: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 47. United States: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 48. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 49. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 50. Canada: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 51. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 52. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 53. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 54. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 55. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 56. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 57. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 58. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 59. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 60. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 61. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 62. Canada: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 63. Canada: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 64. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 65. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 66. Mexico: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 67. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 68. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 69. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 70. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 71. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 72. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 73. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 74. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 75. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 76. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 77. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 78. Mexico: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 79. Mexico: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 80. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 81. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 82. Europe: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 83. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 84. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 85. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 86. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 87. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 88. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 89. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 90. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 91. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 92. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 93. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 94. Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 95. Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 96. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 97. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 98. Germany: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 99. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 100. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 101. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 102. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 103. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 104. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 105. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 106. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 107. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 108. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 109. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 110. Germany: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 111. Germany: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 112. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 113. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 114. United Kingdom: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 115. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 116. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 117. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 118. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 119. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 120. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 121. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 122. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 123. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 124. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 125. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 126. United Kingdom: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 127. United Kingdom: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 128. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 129. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 130. France: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 131. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 132. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 133. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 134. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 135. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 136. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 137. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 138. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 139. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 140. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 141. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 142. France: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 143. France: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 144. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 145. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 146. Spain: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 147. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 148. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 149. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 150. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 151. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 152. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 153. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 154. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 155. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 156. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 157. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 158. Spain: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 159. Spain: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 160. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 161. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 162. Italy: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 163. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 164. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 165. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 166. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 167. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 168. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 169. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 170. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 171. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 172. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 173. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 174. Italy: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 175. Italy: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 176. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 177. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 178. Rest of Europe: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 179. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 180. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 181. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 182. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 183. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 184. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 185. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 186. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 187. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 188. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 189. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 190. Rest of Europe: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 191. Rest of Europe: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 192. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 193. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 194. Asia Pacific: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 195. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 196. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 197. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 198. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 199. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 200. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 201. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 202. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 203. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 204. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 205. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 206. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 207. Asia Pacific: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 208. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 209. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 210. China: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 211. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 212. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 213. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 214. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 215. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 216. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 217. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 218. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 219. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 220. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 221. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 222. China: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 223. China: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 224. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 225. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 226. Japan: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 227. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 228. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 229. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 230. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 231. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 232. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 233. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 234. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 235. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 236. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 237. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 238. Japan: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 239. Japan: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 240. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 241. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 242. India: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 243. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 244. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 245. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 246. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 247. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 248. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 249. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 250. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 251. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 252. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 253. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 254. India: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 255. India: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 256. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 257. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 258. Australia: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 259. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 260. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 261. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 262. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 263. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 264. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 265. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 266. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 267. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 268. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 269. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 270. Australia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 271. Australia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 272. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 273. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 274. South Korea: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 275. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 276. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 277. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 278. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 279. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 280. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 281. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 282. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 283. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 284. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 285. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 286. South Korea: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 287. South Korea: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 288. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 289. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 290. Rest of APAC: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 291. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 292. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 293. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 294. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 295. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 296. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 297. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 298. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 299. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 300. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 301. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 302. Rest of APAC: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 303. Rest of APAC: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 304. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 305. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 306. Middle East and Africa: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 307. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 308. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 309. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 310. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 311. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 312. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 313. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 314. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 315. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 316. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 317. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 318. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 319. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 320. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 321. Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 322. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 323. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 324. Saudi Arabia: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 325. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 326. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 327. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 328. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 329. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 330. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 331. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 332. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 333. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 334. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 335. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 336. Saudi Arabia: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 337. Saudi Arabia: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 338. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 339. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 340. South Africa: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 341. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 342. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 343. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 344. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 345. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 346. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 347. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 348. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 349. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 350. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 351. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 352. South Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 353. South Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 354. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 355. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 356. United Arab Emirates: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 357. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 358. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 359. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 360. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 361. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 362. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 363. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 364. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 365. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 366. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 367. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 368. United Arab Emirates: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 369. United Arab Emirates: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 370. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 371. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 372. Rest of Middle East and Africa: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 373. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 374. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 375. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 376. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 377. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 378. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 379. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 380. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 381. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 382. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 383. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 384. Rest of Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 385. Rest of Middle East and Africa: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 386. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 387. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 388. South and Central America: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 389. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 390. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 391. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 392. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 393. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 394. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 395. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 396. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 397. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 398. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 399. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 400. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 401. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 402. South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 403. South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 404. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 405. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 406. Brazil: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 407. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 408. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 409. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 410. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 411. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 412. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 413. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 414. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 415. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 416. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 417. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 418. Brazil: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 419. Brazil: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 420. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 421. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 422. Argentina: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 423. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 424. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 425. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 426. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 427. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 428. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 429. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 430. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 431. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 432. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 433. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 434. Argentina: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 435. Argentina: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 436. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Blood Component

Table 437. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 438. Rest of South and Central America: Donor Blood Component Market – Volume, 2021–2024 (Unit Million) – by Blood Component

Table 439. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Blood Component

Table 440. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Indication

Table 441. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication

Table 442. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Immunosuppression

Table 443. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Immunosuppression

Table 444. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Oncology

Table 445. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Oncology

Table 446. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Application

Table 447. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application

Table 448. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by Age Group

Table 449. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by Age Group

Table 450. Rest of South and Central America: Donor Blood Component Market – Revenue, 2021–2024 (US$ Million) – by End User

Table 451. Rest of South and Central America: Donor Blood Component Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User

Table 452. Recent Organic Growth Strategies in the Donor Blood Component Market

Table 453. Recent Inorganic Growth Strategies in the Donor Blood Component Market

Table 454. Glossary of Terms, Donor Blood Component Market

List of Figures

Figure 1. Donor Blood Component Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Donor Blood Component Market Revenue (US$ Million), 2021–2031

Figure 5. Donor Blood Component Market Share (%) – by Blood Component (2024 and 2031)

Figure 6. Red Blood Cells: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. White blood cells: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Platelets: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Plasma: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Donor Blood Component Market Share (%) – by Indication (2024 and 2031)

Figure 12. Immunosuppression: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. Oncology: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Donor Blood Component Market Share (%) – by Application (2024 and 2031)

Figure 15. Anemia management: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Thrombocytopenia treatment: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Coagulopathy Correction: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Supportive care during chemotherapy: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Surgery: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20. Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21. Donor Blood Component Market Share (%) – by Age Group (2024 and 2031)

Figure 22. Adult: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23. Child: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24. Donor Blood Component Market Share (%) – by End User (2024 and 2031)

Figure 25. Hospitals: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26. Oncology centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27. Transplant centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 28. Ambulatory surgical centers: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 29. Others: Donor Blood Component Market – Revenue and Forecast to 2031 (US$ Million)

Figure 30. North America: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

Figure 31. North America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 32. United States: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 33. Canada: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 34. Mexico: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 35. Europe: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

Figure 36. Europe: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 37. Germany: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 38. United Kingdom: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 39. France: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 40. Spain: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 41. Italy: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 42. Rest of Europe: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 43. Asia Pacific: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

Figure 44. Asia Pacific: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 45. China: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 46. Japan: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 47. India: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 48. Australia: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 49. South Korea: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 50. Rest of APAC: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 51. Middle East and Africa: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

Figure 52. Middle East and Africa: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 53. Saudi Arabia: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 54. South Africa: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 55. United Arab Emirates: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 56. Rest of Middle East and Africa: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 57. South and Central America: Donor Blood Component Market – Revenue, 2021–2031 (US$ Million)

Figure 58. South and Central America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 59. Brazil: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 60. Argentina: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 61. Rest of South and Central America: Donor Blood Component Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 62. Growth Strategies in the Donor Blood Component Market

The List of Companies - Donor Blood Components Market

Mayo Clinic
Cleveland Clinic
Johns Hopkins Medicine
Memorial Sloan Kettering Cancer Center
Singapore General Hospital
King’s College Hospital
Charité University Hospital
Royal Melbourne Hospital
St. Michael’s Hospital
Tokyo Medical University Hospital
Massachusetts General Hospital
UCLA Medical Center
NewYork-Presbyterian Hospital
Karolinska University Hospital
The Royal Free Hospital
Zentrum für Transfusionsmedizin (ZTM)
Asan Medical Center
Apollo Hospitals
Cecil Memorial Hospital
King Fahd Military Medical Complex
Bumrungrad International Hospital
Hospital das Clínicas
Aga Khan University Hospital
University of California, San Francisco (UCSF) Medical Center
Peking Union Medical College Hospital
The Aga Khan University Hospital (Nairobi)
Fuda Cancer Hospital
St. Thomas' Hospital
Beijing Tiantan Hospital
Cairo University Hospital

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.